Avaleht › Südamepuudulikkus › Louisiana
Südamepuudulikkus kliinilised uuringud osariigis Louisiana
18 uuringut haiguse Südamepuudulikkus jaoks otsivad osalejaid osariigis Louisiana.
Linnad osariigis Louisiana
- New Orleans7 uuringut
- Houma7 uuringut
- Hammond5 uuringut
- Baton Rouge5 uuringut
- Monroe5 uuringut
- Shreveport4 uuringut
- Lafayette3 uuringut
Ametlik uuringutekst (inglise keeles)
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, West Monroe
VärbamineFaas 3
Vanused 18–130 · Kõik sood · Uuendatud 2. okt 2026 · NCT06307652A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Heart Clinic of Hammond, Hammond
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 1. okt 2026 · NCT06935370A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Grace Research, LLC-Bossier City-51040, Bossier City
- Heart Clinic of Hammond, Hammond
- Grace Research, LLC-Shreveport-64616, Shreveport
- ja veel 1
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 1. okt 2026 · NCT06424288A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Cardiovascular Institute of the South, Houma
Värbamine
Vanused 18–85 · Kõik sood · Uuendatud 1. okt 2026 · NCT07214376A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Bossier City
- Research Site, Covington
- Research Site, Lafayette
- ja veel 3
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- University Medical Center New Orleans, New Orleans
VärbamineFaas 3
Vanused 18–85 · Kõik sood · Uuendatud 24. sept 2026 · NCT06736574Alleviant ALLAY-HFrEF Study
- Cardiovascular Institute of the South, Houma
- University Medical Center New Orleans, New Orleans
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. sept 2026 · NCT06812533Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Our Lady of the Lake Medical Center, Baton Rouge
- Louisiana Heart Center - Hammond, Covington
- Heart Clinic of Hammond, Hammond
- ja veel 1
VärbamineFaas 3
Vanused 18–99 · Kõik sood · Uuendatud 16. sept 2026 · NCT07037459Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Alexandria
- Research Site, Bossier City
- Research Site, Shreveport
VärbamineFaas 3
Vanused 40 ja vanemad · Kõik sood · Uuendatud 15. sept 2026 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- CON-10030 Baton Rouge, LA Investigational Site, Baton Rouge
- CON-10090, West Monroe, LA, West Monroe
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 10. sept 2026 · NCT06024746A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Baton Rouge, LA Investigative Site 10030, Baton Rouge
- Hammond, LA Investigative Site 10106, Hammond
- West Monroe, LA Investigative Site 10090, West Monroe
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 10. sept 2026 · NCT06008197A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
- Local Institution - 155, Houma
VärbamineFaas 2
Vanused 30–84 · Kõik sood · Uuendatud 31. aug 2026 · NCT07795814LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
- Tenax Investigational Site, New Orleans
- Tenax Investigational Site, West Monroe
VärbamineFaas 3
Vanused 18–85 · Kõik sood · Uuendatud 19. aug 2026 · NCT07288398A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Grace Research, LLC, Bossier City
- Horizon Research Group of Opelousas, LLC, Eunice
- Cardiovascular Institute of the South, Houma
- ja veel 2
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 18. aug 2026 · NCT07567001Alleviant ALLAY-HF Study
- Cardiovascular Institute of the South, Houma
- University Medical Center New Orleans, New Orleans
Värbamine
Vanused 40 ja vanemad · Kõik sood · Uuendatud 14. aug 2026 · NCT05685303A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- FIN-10030, Baton Rouge, LA, Baton Rouge
- FIN-10106, Hammond, LA, Hammond
- FIN-10090, West Monroe, LA, West Monroe
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 10. juuli 2026 · NCT06033950The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Cardiovascular Institute South, Houma
- Ochsner Health System, New Orleans
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 13. apr 2026 · NCT03142152AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
- Cardiovascular Institute of the South, Houma
- Cardiovascular Institute of the South, Lafayette
- University Medical Center New Orleans, New Orleans
VärbamineVaatlusuuring
Vanused 22 ja vanemad · Kõik sood · Uuendatud 26. märts 2025 · NCT06378632Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.